Naijacrux News:Welcome to Naijacrux Online Forum...remember to register to enjoy much more update!!!New Updates From Naijacrux -Naijacrux Is Now Mobile Friendly - Download Our Android App On Our Forum Rules And Announcement Section.Our App Will be Live On Google Playstore And IOS Store Soon Aswell - CLICK HERE TO DOWNLOAD NAIJACRUX ANDROID APP !!! Dear Guest And Naijacrux Dedicated Members,!!! ,  You Can Now Receive Naijacrux Weekly New Post and Updates Via Email by Subscribing To Our Newsletter Using The Subscribe Button Above The Naijacrux Announcement And Discussion At The Top Home Page!!Never Miss A New Post And Updates Again.!Thank You.  !!!YOU ARE WELCOME TO NAIJACRUX INFORMATIVE LEARNING AND INTERACTIVE FORUM.This Website is an Intensive Forum of Learning We recommend you Register & Login to Enjoy much free stuffs ::>>Also remember to Update your Profile Immediately after registration. Thank you!>>>!!!!To All Advertisers And Patronizers, kindly Send Mail To [email protected] For adverts Placement. thanks!!!


Random Pagan Verse:
After nightfall I hurried back,
But the warriors were all awake,
Lights were burning, blazing torches:
So false proved the path

Author Topic: Hope for People With Deadly Cancers Get Boost as New Drug shows good result  (Read 497 times)

0 Members and 1 Guest are viewing this topic.

Offline legendguru (OP)

  • Global Moderator
  • Hero Member
  • *****
  • Date Registered: Sep 2015
  • Posts: 1140
  • Karma: +1/-0
    • View Profile
Loading...
A new drug is being developed that targets some aggressive cancers that are notoriously hard to cure. If the clinical trials that are underway continue to show promise, the drug may change the way some cancers are treated.

Scientists at Pfizer, the giant pharmaceutical company, and Stemcentrx, a small biotech firm in California recently acquired by AbbVie, have developed this novel drug that targets aggressive breast, ovarian and lung cancer stem cells.

Marc Damelin at Pfizer has been working on this drug, officially called PF-06647020, with Scott Dylla at AbbVie Stemcentrx.

In a Skype interview, Damelin told VOA, "We’re hoping to rip out the cancer by its roots, essentially. Like when you’re weeding a garden, you need to get the roots so the weed doesn’t grow back, and the way we’ve designed this drug, is to go after the roots of the tumor and we deliver the chemotherapy therapy that essential kills those cells."

Relapses are common in aggressive forms of cancer, including triple-negative breast cancer, ovarian cancer and non-small cell lung cancer, which make them hard to cure.

The drug has already proven safe and effective in mice and in monkeys, and human trials are underway.

"The therapy is, essentially, a guided missile," Damelin said.

Dylla at AbbVie Stemcentrx explained to VOA that the missile is an antibody molecule which attaches itself to a developing cancer cell and is able to enter the cell like a Trojan horse. Because the scientists also attached a cancer-fighting drug to the antibody, the drug delivers chemotherapy directly to cancer cells and kills them.

The missile’s target is a protein called PTK7 which is found in abundance in these particular cancer cells.

Early clinical trials are underway with patients whose cancers did not respond to other treatments or had relapsed. Damelin says nearly a third of participants with ovarian cancer are showing a positive response.

Dylla said patients in the current trial with triple negative breast cancer and non-small cell lung cancer are also responding well, although he didn't provide the percentages.

He said even though this is an early clinical trial, "The responses are clearly drug related responses given that the only therapy patients are being given is our drug." A larger human trial is scheduled to begin later this year.

Right now the researchers don't know if this new drug would replace standard chemotherapy, radiation or surgery, or would complement those procedures, but Dylla said that is the hope. If it works, it could replace standard chemotherapy and the treatment would be a lot less toxic.

Damelin said this drug might also help patients with cancer of the stomach, esophagus and prostate, and an aggressive type of leukemia because the scientists have antibodies for these particular cancers.

The hope is that PF-06647020 could revolutionize the way these particular cancers are treated, in addition to dramatically extending the lives of those with these deadly cancers.


 

 

Half of World's People Can't get Basic Health Services-World Health Organization

Started by naij

Replies: 0
Views: 427
Last post December 15, 2017, 08:09:34 AM
by naij
People With Sinus Infections Stay on Antibiotics Too Long, Study Reveals

Started by newspostng

Replies: 0
Views: 353
Last post March 30, 2018, 10:18:44 PM
by newspostng
Fresh study shows Ebola Virus Can Remain in Semen Longer Than Thought

Started by yungcrux

Replies: 0
Views: 396
Last post September 02, 2016, 06:52:00 AM
by yungcrux
Scientist Says Trojan Horse Antibody Strategy Shows Promise Against Ebola Virus

Started by newspostng

Replies: 0
Views: 422
Last post September 09, 2016, 07:59:36 AM
by newspostng
Study shows Omega-3 Fatty Acids Reduce Asthma Risk in Children

Started by mastercode

Replies: 0
Views: 546
Last post January 02, 2017, 11:05:51 AM
by mastercode
Report Shows Test-tube Immune Systems Can Speed Vaccine Development

Started by naij

Replies: 0
Views: 424
Last post July 26, 2017, 12:02:04 AM
by naij
Report shows Multi gene Test May Detect Risk for Heart Disease and More

Started by punch

Replies: 0
Views: 1679
Last post August 15, 2018, 07:18:57 AM
by punch
Report shows Fake Drugs Kill Tens of Thousands in Africa Each Year

Started by lindaikeji

Replies: 0
Views: 1
Last post Today at 01:36:32 AM
by lindaikeji
Rubber Robots Could Help People with Weak Muscles - Medical Experts Says

Started by Postmaster

Replies: 0
Views: 482
Last post March 10, 2017, 04:40:27 AM
by Postmaster
Hunger Imminent For More Than a Billion People Who Lives on Degraded Land

Started by mastercode

Replies: 0
Views: 484
Last post September 13, 2017, 12:37:30 AM
by mastercode